Trends in antibiotic susceptibility of bloodstream pathogens in hospitalized patients in France, 1996 to 2007

被引:11
作者
Decousser, Jean-Winoc [1 ]
Lamy, Brigitte [2 ]
Pina, Patrick [3 ]
Allouch, Pierre Yves [4 ]
机构
[1] CHU Antoine Beclere, AP HP, Dept Bacteriol & Infect Control, F-92141 Clamart, France
[2] Ctr Hosp Bassin Thau, Dept Biol, F-34200 Sete, France
[3] Hop Plaisir Grignon, Dept Internal Med B, F-78310 Plaisir, France
[4] Ctr Hosp Versailles Andre Mignot, Dept Infect Control, F-78157 Le Chesnay, France
关键词
Bloodstream infection; France; Antimicrobial susceptibility; Trends; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; ESCHERICHIA-COLI; ENTEROBACTERIACEAE; PREVALENCE; SURVEILLANCE; BACTEREMIA; MORTALITY;
D O I
10.1016/j.diagmicrobio.2009.10.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Nationwide surveys of antimicrobial susceptibility of bacteria isolated from bloodstream infections are required to fit empiric therapy to recent trends and detect emerging resistance. We report the results of a French national prospective survey based on the College of Bacteriology Virology and Hygiene study group network performed each October during the 1996 to 2007 period, with focus on Enterobacteriaceae (7708 isolates) and Staphylococcus aureus (2271 isolates). The most relevant antimicrobial susceptibilities trends were i) a decrease in fluoroquinolones susceptibility among Enterobacteriaceae (96-90%, P < 0.0001) and Escherichia coli isolates (98-89%, P < 0.0001), respectively, ii) the slight but significant decrease in cefotaxime susceptibility among E. coli (P = 0.016), and iii) the significant increase in gentamicin susceptibility among S. aureus strains (P = 0.016). This survey reports antibiotic susceptibility of bloodstream pathogens in France. The empiric use of fluoroquinolones in severe infections should be cautiously monitored by thorough clinical and microbiologic follow-up. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:292 / 300
页数:9
相关论文
共 34 条
[1]   Surveillance of antimicrobial resistance - what, how and whither? [J].
Bax, R ;
Bywater, R ;
Cornaglia, G ;
Goossens, H ;
Hunter, P ;
Isham, V ;
Jarlier, V ;
Jones, R ;
Phillips, I ;
Sahm, D ;
Senn, S ;
Struelens, M ;
Taylor, D ;
White, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (06) :316-325
[2]   Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002) [J].
Biedenbach, DJ ;
Moet, GJ ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (01) :59-69
[3]   European recommendations for antimicrobial resistance surveillance [J].
Cornaglia, G ;
Hryniewicz, W ;
Jarlier, V ;
Kahlmeter, G ;
Mittermayer, H ;
Stratchounski, L ;
Baquero, F .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (04) :349-383
[4]  
DALGAARD P, 2002, INTRO STAT, P133
[5]  
DALGAARD P, 2002, INTRO STAT, P112
[6]   Invasive Streptococcus pneumoniae in France:: Antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002 [J].
Decousser, JW ;
Pina, P ;
Viguier, F ;
Picot, F ;
Courvalin, P ;
Allouch, P ;
Akli, J ;
Alba-Sauviat, C ;
Aubert, G ;
Amirault, P ;
Assens, J ;
Aubry, JP ;
Aucher, P ;
Auvray, C ;
Bailly, A ;
Barrans, B ;
Barraud, D ;
Benoit, C ;
Bichler, E ;
Biessy, H ;
Bietrix, M ;
Bineau, P ;
Blanc, V ;
Bland, S ;
Boisivon, A ;
Boucaud-Maitre, Y ;
Bouguigny-Saison, C ;
Brisou, P ;
Brovedani, S ;
Caillaux, M ;
Cancet, B ;
Carre-Cavelier, J ;
Cartolano, GL ;
Cartron, J ;
Chambreuil, G ;
Chantelat, P ;
Chapelle, A ;
Chaplain, C ;
Chardon, H ;
Chaurang, B ;
Clarac, A ;
Clergeau, P ;
Collot, E ;
Courrier, P ;
Danjoux, MF ;
Darchis, JP ;
de Montclos, H ;
Decoster, A ;
Delamare, C ;
Delarbre, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3636-3639
[7]   Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey [J].
Decousser, JW ;
Pina, P ;
Picot, E ;
Delalande, C ;
Pangon, B ;
Courvalin, P ;
Allouch, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (05) :1213-1222
[8]   Prevalence of antibiotic resistance in Escherichia coli:: overview of geographical, temporal, and methodological variations [J].
Erb, A. ;
Stuermer, T. ;
Marre, R. ;
Brenner, H. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (02) :83-90
[9]   Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals [J].
Fridkin, SK ;
Hill, HA ;
Volkova, NV ;
Edwards, JR ;
Lawton, RM ;
Gaynes, RP ;
McGowan, JE .
EMERGING INFECTIOUS DISEASES, 2002, 8 (07) :697-701
[10]   Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-β-lactamase-producing Enterobacteriaceae in France [J].
Galas, Muriel ;
Decousser, Jean-Winoc ;
Breton, Nelly ;
Godard, Thierry ;
Allouch, Pierre Yves ;
Pina, Patrick .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) :786-789